JOSEPH LACOB
CIK 1215490 · last filed 2026-05-22
JOSEPH LACOB is a corporate insider who has filed 72 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ALGN, was dated May 22, 2026. Across all open-market trades the lifetime net is −$95.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $208.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$208.61M
4
72
-$95.85M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALGN | Director | 1,180,016 | $174.84 | $206.31M | -$95.85M | 52 | 2026-05-22 |
| NPCE | Director | 142,928 | $15.64 | $2.24M | $0 | 11 | 2026-03-24 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | Director | 1,179,804 | — | — | $0 | 5 | 2011-06-06 |
| EHTH | Director | 31,786 | $1.81 | $57.5K | $0 | 4 | 2007-11-09 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | ALGN | Mixed | +1,745 | $0 | EDGAR |
| 2026-03-24 | NPCE | Grant (A) | +865 | $11.2K | EDGAR |
| 2025-12-23 | NPCE | Grant (A) | +678 | $11.2K | EDGAR |
| 2025-09-22 | NPCE | Grant (A) | +1,131 | $11.2K | EDGAR |
| 2025-06-24 | NPCE | Grant (A) | +11,696 | $101.2K | EDGAR |
| 2025-06-09 | NPCE | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | ALGN | Mixed | +1,148 | $0 | EDGAR |
| 2024-06-11 | NPCE | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | ALGN | Grant (A) | — | $0 | EDGAR |
| 2024-05-21 | ALGN | Exer (M) | +1,029 | $0 | EDGAR |